Oberweis Asset Management Inc Krystal Biotech, Inc. Transaction History
Oberweis Asset Management Inc
- $2.02 Billion
- Q4 2024
A detailed history of Oberweis Asset Management Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Oberweis Asset Management Inc holds 46,800 shares of KRYS stock, worth $8.76 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
46,800
Previous 46,800
-0.0%
Holding current value
$8.76 Million
Previous $8.51 Million
13.85%
% of portfolio
0.36%
Previous 0.46%
Shares
3 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$739 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$539 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$492 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$239 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$165 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.8B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...